VESSELON
Vesselon is developing novel therapeutic immuno-oncology complexes that are protected in circulation and actively targeted to tumors using an FDA approved lipid microsphere drug as the backbone of its encapsulated drug/drug platform technology. Furthermore, the complexes are formed at the time of administration (rather than at the drug manufacturing stage) enabling the creation of new complexes from already approved therapeutics. The company is developing a next-generation, multi-targeted enca... psulated oncolytic virus complex that has been shown in preclinical models to be effective at low titers across a wide range of tumors. Also, the company is developing an encapsulated recombinant interleukin-2 complex targeting clinically relevant dosages to solid tumors with systemic exposure far below that which could cause adverse events. Vesselon’s proprietary complexes can be applied across a spectrum of cancers and other serious diseases in a variety of drug classes.
VESSELON
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2012-01-01
Address:
Norwalk, Connecticut, United States
Country:
United States
Website Url:
http://www.vesselon.com
Total Employee:
1+
Status:
Active
Contact:
(203) 989-0500
Email Addresses:
[email protected].
Total Funding:
1.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Font Awesome Microsoft Exchange Online Office 365 Mail ReCAPTCHA GoDaddy DNS ReCAPTCHA V2
Current Employees Featured
Founder
Investors List
CTNext
CTNext investment in Pre Seed Round - Vesselon
Connecticut Innovations
Connecticut Innovations investment in Pre Seed Round - Vesselon
Official Site Inspections
http://www.vesselon.com
- Host name: 132.172.62.50.host.secureserver.net
- IP address: 50.62.172.132
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
